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1. Introduction  
Actually, each clinical and/or biochemical laboratory has responsibility for demonstrating 
its competence and therefore must obtain results of good quality. Medical laboratories 
provide vital medical services to different clients: clinicians requesting a test, patients from 
whom the sample was collected, public health and medical-legal instances, referral 
laboratories and authoritative bodies. All expect results that are accurate and obtained in an 
effective manner, within a suitable time frame and at acceptable cost. There are different 
ways of achieving the end results, but compliance with International Organization for 
Standardization (ISO) 15189, the international standard for the accreditation of medical 
laboratories, is becoming progressively accepted as the optimal approach to assuring quality 
in medical testing. As result, the accreditation of clinical laboratories is shifting from being a 
“recommendation” to becoming a “requirement” in many countries throughout Europe and 
in the other countries around the world (Berwouts, 2010). Accreditation is defined by ISO as 
the “Procedure by which an authoritative body gives formal recognition that a body or 
person is competent to carry out specific tasks”. Although accreditation also considers the 
quality management system (QMS), it has additional formal requirements of technical 
competence, including initial and continuous training of personnel, validation of methods and 
instruments, and internal and external quality control. 
A good QMS in the laboratory has a lot of advantages such as increased transparency, 
traceability, uniformity, work satisfaction and better focus on critical points. On the 
contrary, it will require extra time on aspects such as document control and there is a danger 
of losing critical attitude and curbing innovation and changes. Therefore, a formal 
accreditation and the linked periodical audits are stimulant for keeping the quality system 
(QS) alive. Without accreditation, there is a danger of giving less attention to quality 
improvement. In addition, accreditation is a good way to demonstrate and attest 
competence and a worldwide tool to recognize laboratories. Finally, all parties (patients, 
families, the laboratory and clinicians) are benefited through better processes and quality of 
results (Berwouts, 2010). 
All essential elements of QS are covered by the ISO 15189 accreditation standard in two 
distinct chapters: management requirements and technical requirements. Technical elements 
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enclose personnel and training, accommodation, equipment, validation and assuring quality 
of examination procedures by internal quality control (IQC), external quality control (EQA), 
maintenance and calibration. 
ISO 15189 standard emphasizes so in the quality of contributions to patient care as in 
laboratory and management procedures and specifies the quality management system 
requirements, in particular to medical laboratories and stages: 
<<The laboratory shall use only validated procedures for confirming that the examination 
procedures are suitable for intended use>>, <<The validation shall be as extensive as are 
necessary to meet the needs in the given application or field of application>>, and 
<<Procedures need to be periodically revalidated in view if changing conditions and 
technical advances>>. 
IQC is an internal verification that the test yields consistent results day after day; in the 
other words, the identification measure of precision, but not necessarily of accuracy. ISO 
15189 requires that “the laboratory shall design IQC systems that verify the attainment of 
the intended quality of results”. On the hand, the laboratory should avoid mistakes (ISO 
15189, 5.6.1.) in the process of handling samples, requests, examinations, reports and so on; 
on the other, the laboratory should determine uncertainty (ISO 15189, 5.6.2) where relevant 
and possible. For each test, the laboratory should identify and define potential errors, risks 
and challenges (typically, during the validation phase); subsequently, specific IQC should 
be defined to assure each risk and potential problem. 
EQA is an important complement to IQC in which a large number of laboratories are 
provided with the same material and required to return results to a coordinating centre. The 
results are compared to determine the accuracy of the individual laboratory. In addition, 
EQA provides continuous education and training for laboratories as well. Accredited 
laboratories are required to “participate in interlaboratory comparisons such as those 
organized by EQA schemes” (ISO 15189, 5.6.4). EQA should, as far as possible, cover the 
entire range of tests, and the entire examination process, from sample reception, preparation 
and analysis to interpretation and reporting (ISO 15189 5.6.5). For some specific tests, no 
EQA scheme exists. ISO 15189 (5.6.5) states “whenever a formal laboratory comparison 
programme is not available, the laboratory shall develop a mechanism for determining the 
acceptability of procedures nor otherwise evaluated”; examples include reference materials 
or interlaboratory exchange. Interlaboratory comparisons should cover the scope of services 
offered and there should be a formal mechanism of review and comparison of results. 
Used together, IQC and EQA provide a method of ensuring accuracy and consistency of 
results and are vital tools in the laboratory. The relation between precision and accuracy 
may be illustrated by the familiar example of shooting arrows at a target (Berwouts, 2010; 
Burnett, 2006) (figure 1). 
The results provided by the clinical/medical laboratory must be accurate to allow a correct 
clinical interpretation and to be comparable with earlier or later and between laboratories. 
So the purpose of this chapter is to establish a set of guidelines and recommendations to 
help personnel carry out their work in clinical/medical laboratories that are accredited or 
under accreditation by ISO 15189. It is necessary to establish and define the different 
procedures validation, the fundamental guidelines for the proper design of the validation, 
the recommendations to validate an established method in the laboratory, and the different 
parameters to be assessed. 
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Precise, but inaccurate
IQC OK
EQA fails
Precise, and accurate
IQC OK
EQA OK
IQC: Internal Quality Control
EQA: External Quality assessment  
Fig. 1. Accuracy and precision. 
2. Validation design of a method 
Diagnostic validation is a formal requirement of accreditation standards, including ISO 17025 
and ISO 15189, those tests/methods and instruments must be validated before diagnostic 
use to ensure reliable results for patients, clinicians or referring laboratories and their 
quality must be maintained throughout use. In other words, the laboratory must 
demonstrate that their tests/methods are fit for the intended use before application to 
patient samples. Figure 2 shows a summary of what ISO 15189 states with regard to 
validation (Berwouts, 2010; Burnett & C. Blair, 2001, Burnett et al., 2002; Burnett, 2006). 
Although the concept of validation makes explicit reference to the purely analytical aspects 
may also include preanalytical and sampling procedures, handling and transport. 
At a minimum, the techniques used to determine the performance of a method should be 
one or more of the following:  
- Calibration using reference standards or reference materials or traceable to these  
- Comparison of results obtained with other methods 
- Interlaboratory comparisons 
- Systematic evaluation of the factors that influence outcomes 
- Estimate of the uncertainty of the results based on scientific knowledge of theoretical 
principles of the method and practical experience.  
In any case, analytical methods must be those that meet customer requirements, that is, 
those that provide clinically useful information. Thus, an analytical method for 
determination of aluminium in serum based on the complexation of this element with 8-
hydroxyquinoline and quantification by fluorimetry can have high reliability but its 
detection limit is at least an order of magnitude above the upper limit of the reference 
element, which makes this method, does not meet customer requirements. 
There are publications that provide general methods of evaluation of analytical methods 
including the following: 
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1. Definition of the evaluation protocol that registers the results of the measurements. 
2. Determining the range of application and dilution mechanisms, if any. 
3. Identify the components of precision in the day, every day. 
4. To determine the accuracy through recovery studies before a definitive method or 
reference, if any. 
5. To determine the sensitivity. 
6. Estimate the limit of detection and quantification (and others if applicable). 
7. To study the specificity of the method, checking for interference. 
8. Establishing the reference range. 
9. Document the validity of the method. 
 
 
Fig. 2. Validation requirements according ISO 15189:2007. 
Regarding the validation and control of analytical procedures, paragraph 5.5 of ISO 15189: 
2007 specifies to be used those procedures "that have been published by experts or 
international guidelines, national or regional". Own procedures "must be properly validated 
for its intended use and fully documented". 
So, ISO 15189: 2007 says "as appropriate, the documentation should include the following: 
technical specifications (e.g., linearity, precision, accuracy, expressed as a measurement 
uncertainty limit of detection, measurement, sensitivity and specificity, and interference)" 
(ISO 15189, 5.5.3). 
When a unit or section of a clinical/medical laboratory chooses to engage in the 
accreditation ISO 15189, must be aware that although the analytical methods which usually 
works have been validated in its implementation must be validated in time. 
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A validation process like any other requires a series of planning, execution and control to 
ensure that the results come to fruition. 
a. Planning: 
 Definition responsible for performing the validation process. 
 Definition of objectives and internal requirements applied the method to validate 
(purpose, parameters to measure in the matrix or matrices to be determined). 
 Definition and documentation of the method (procedure for validation). 
b. Implementation: implementation of activities, results obtained and recorded (date, 
operators and results). 
c. Control: 
 Verification of compliance with targets. 
 Final Declaration of the appropriateness of the procedure defined. 
a. Planning consists of the following phases:  
1) Assign responsibility. In this phase it will be defined a person responsible for carrying out 
the validation process and deciding the outcome. This person can count on help from others, 
but he is responsible for making decisions so, he must have a proper qualification; 2) 
Definition of the characteristics and requirements applied to the method: The definition of 
requirements has to do with the intended use of the method ( i.e. as property or analyte, the 
matrix or matrices in which they will determine the use that will make the test results and 
legal requirements or economic policy to be applied to test results), from the specified 
requirements and based on a literature search using other standards, etc. There is a design 
and optimization phase of the procedure that is performed by laboratory. This is the stage 
where, for example for an instrumental method, you must establish a priori the linearity of 
the method, the working range, the limit of detection and quantification is desired, the 
accuracy and precision fit. In short what features the laboratory can apply the method to the 
intended use; 3) Description documented procedure:  It should be sufficiently detailed to 
ensure its proper performance and repeatability. This ensures that all laboratory personnel 
that are qualified can do just as the method with comparable results. 
To accomplish this phase can be helpful in establishing a suitable index of the case as the 
reference standard. 
b. Implementation: Outcome is based on the realization of a series of tests and experiments 
that occur as a result values for the parameters defined in the requirements. These 
parameters can be variable depending on the type of method applied and the 
requirements and can include accuracy, precision, limit of detection, limit of quantization, 
selectivity, etc. 
c. Control: The control is the verification of compliance and the final declaration. 1) 
Verification of compliance: As a result of the implementation of activities will be decided 
whether the values meet the specified requirements, in which case proceed to establish 
which checks should be made to the method as regular monitoring to confirm that remain 
requirements requested at the time of validation, e.g. using a control pattern periodically 
check the parameters of the regression line, etc., proceeding to their inclusion in the 
proceedings and preparing a final edition of the same. Otherwise you may be assessed if an 
amendment to the previously established requirements. 2) Final Statement: All the 
validation process should conclude with a formal statement of the adequacy of the 
procedure defined as stated is suitable for their intended use, according to specified 
requirements (Burnett & C. Blair, 2001; Burnett et al., 2001; Burnett, 2006). 
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2.1 Types and methods of validation 
The laboratory shall validate examination procedures from non standard methods, 
laboratory designed or development methods, standard methods used outside their 
intended scope and modified validated methods. 
When examination procedures have been validated by the method developer (i.e., the 
manufacturer or author of a published procedure), the laboratory shall obtain information 
from the method developer to confirm that the performance characteristics of the method 
are appropriate for its intended use. When changes are made to a validated examination 
procedure, the influence of such changes shall be documented and, if appropriate, a new 
validation shall be carried out. 
Examination procedures from method developers that used without modification shall be 
subject to verification before being introduced into routine use. The verification shall 
confirm, through provision of objective evidence (performance characteristics), that the 
performance claims for the examination method have been met. The performance claims for 
the examination method confirmed during the verification process shall be those relevant to 
the intended use of the examination results. 
Verification and validation are two slightly different procedures (figure 3). By default, all 
new laboratory procedures must be validated before application to clinical testing. In 
addition, a validation is necessary when major technical modifications to existing methods 
are carried out or when the performance of existing methods has been shown to be 
unsatisfactory (Berwouts, 2010; Hauck et al., 2008). 
 
Non standard method
Laboratory designed by developed method
Standard method used outside their intended scope
Modified validated method
VALIDATION
Before use as diagnostic test/method
DEFINE PERFORMANCE CHARACTERISTICS,
As extensive as is necessary to confirm,
Throug the provision of objective evidence,
That the specific requirements for the intended use have been fulfilled
DOCUMENT and record the results obtained and the 
procedure used for the validation
CONTINUOUS VALIDATION
Existing METHOD with defined performance
Existing METHOD used after repair
VERIFICATION
Before use as diagnostic test/method
COMPARE PERFORMANCE CHARACTERISTICS, with 
specifications.
Be aware of and respect specified requirements
DOCUMENT and record the results obtained and the 
procedure used for the validation
CONTINUOUS VALIDATION
VALIDATION VS VERIFICATION 
OF A METHOD IN A CLINICAL/MEDICAL LABORATORY
 
Fig. 3. Validation vs verification in diagnostic methods. 
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The validation or verification of methods, as defined in figure 4, is a normal requirement for 
the accreditation of laboratories according to the two major international standards 
applicable to clinical/medical laboratories, ISO 15189 and ISO 17025. Although the general 
requirements are clearly stablished (figure 4), the standards provide very little guidance 
about the detailed requirements or procedures. 
Before a test/method can be validated, it is necessary to establish (a) that the particular 
measurements are diagnostically useful and (b) that the correct analyte(s), and only the 
correct analyte(s), are measured. 
Full validation is required when is no suitable performance specification available, for 
example, with novel tests/methods or technologies. This process involves assessing the 
performance of the test/method in comparison with a “gold standard” or reference 
test/method that is capable of assigning the sample status without error. In simple terms, 
validation can be seen as a process to determine whether the laboratory is “performing the 
correct test/method”. Validation data can be used to assess the accuracy of either the 
technology or the specific test/method. Generally speaking, the generic validation of a novel 
technology should be performed on a larger scale, ideally in multiple laboratories 
(interlaboratory validation), and should include a much more comprehensive investigation 
of the critical parameters relevant to the specific technology to provide the highest chance of 
detecting sources of variation and interference (Berwouts, 2010; Burnett, 2006). 
 
Principle requirements of ISO 157025:2005 Principle requirements od ISO 15189:2007
5.4.2 “Laboratory-developed methods or methods adopted by the
laboratory may also be used if they are appropiate for the intended use
and if they are validated”.
5.4.5.2 “The laboratory shall validate non-standard methods, laboratory-
designed/developed methods, standard methods used outside their
intended scope, and amplifications and modifications of standard
methods to confirm that methods are fit for the intended use. The
validation shall be as extensive as is necessary to meet the needs of the
given application or field or application.The laboratory shall record the
results obtained, the procedure used for validation, and a statement as to
wether the method is fit for the intended use”.
5.4.5.3 “NOTE 1 validation includes specification of the requirements,
determination of the characteristics of the methods, a check that the
requirements can be fulfilled by using the method, and a statement on the
validity. NOTE 3 Validation is always a balance between costs, risks and
technical possibilities, There are many cases in which the range and
uncertainty of the values (eg accuracy, detection limit, selectivity, linearity,
repeatability, robutness and cross-sensivity) can only be given in a
simplified way due to lack of information”.
5.5.1 “[….]If in-house procedures are used, they shall be appropriately 
validated for their intended use and fully documented”.
5.5.2 “The methods and procedures selected for use shall be evaluated 
and found to give satisfactory results before used for medical 
examinations. A review of procedures by the laboratory director or 
designated person shall be understaken initially and at defined 
intervals”.
5.6.2 “The laboratory shall determine the uncertainty of results, where 
relevant and possible”.
 
Fig. 4. Principle requirements of ISO 15189: 2007 and ISO 17025:2005 about validation and 
verification. 
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2.2 Recommendations to validate a method developed in the laboratory 
2.2.1 Quantitative methods 
Two components of analytical accuracy are required to characterize a quantitative method: 
trueness and precision. Trueness expresses how close the methods result is to the reference 
value. Typically, multiple measurements are made for each point and the rest method result 
is taken to be the mean of the replicate results (excluding outliers if necessary). As 
quantitative assays measure a continuous variable, mean results are often represented by a 
regression of data (a regression line is a linear average). Any deviation of this regression 
from the reference indicates a systematic error, which expressed as a bias (i.e., a number 
indicating the size and direction of the deviation from the true result). There are two general 
forms of bias. With constant bias, method results deviate from the reference value by the 
same amount, regardless of that value. With proportional bias, the deviation is proportional 
to the reference value. Both forms of bias can exist simultaneously. Although measurement 
of bias is useful, it is only one component of the measurement uncertainty and gives no 
indication of how dispersed the replicate results are. This dispersal is called precision and 
can be measured by imprecision, that provides an indication of how well a single method 
results is representative of a number of replicates or repetitions. Imprecision is commonly 
expressed as the standard deviation of the replicate results, but is often more informative to 
describe a confidence interval (CI) around the mean result. Precision is subdivided 
according to how replicate analyses are handled an evaluated. 
Repeatability refers to the closeness of agreement between results of test performed on the 
same method items, by the same analyst, on the same instrument, under the same 
conditions in the same location and repeated over a short period of time. Repeatability 
represents “within-run precision”. 
Intermediate precision refers to closeness of agreement between results of methods 
performed on the same method items in a single laboratory but over an extended period of 
time, taking account of normal variation in laboratory conditions such as different operators, 
different equipment and different days. Intermediate precision therefore represents “within-
laboratory, between-run precision” and is therefore a useful measure for inclusion in 
ongoing validation. 
Reproducibility refers to closeness of agreement between results of methods carried out on 
the same method items, taking into account the broadest range of variables encountered in 
real laboratory conditions, including different laboratories. Reproducibility therefore 
represents “inter-laboratory precision”. 
In practical terms, internal laboratory validation will only be concerned with repeatability 
and intermediate precision and in many cases both can be investigated in a single series of 
well-designed experiments. Reduced precision indicates the presence of random error. The 
relationship between the components of analytical accuracy, types of error and the metrics 
used to describe them is illustrated in figure 5. 
Any validation should also consider robustness, which, in the context of a quantitative 
method, could be considered as a measure of precision. However, robustness expresses how 
well a method maintains precision when faced by a specific designed “challenge”, in the 
form of precision does not represent random error. Typical variables in the laboratory 
include sample type, sample handling, sample quality, instrument make and model, reagent 
lots and environmental conditions (e.g., humidity, temperature). Appropriate variables 
should be considered and tested for each specific method. The principle of purposefully 
challenging methods is also applicable to both categorical and qualitative methods and 
www.intechopen.com
Procedures for Validation of  
Diagnostic Methods in Clinical Laboratory Accredited by ISO 15189 
 
217 
should be considered in the validation as well. Robustness can be considered as a useful 
prediction of expected intermediate precision (Berwouts, 2010). 
As trueness and precision represent two different forms of error, they need to be treated in 
different ways. In practice, systematic error or bias can often be resolved by using a 
correction factor; constant bias requires an additive correction factor, whereas proportional 
bias requires a multiplicative correction factor. 
For quantitative methods, particularly those requiring absolute quantification, it is most 
effective to estimate analytical accuracy on an ongoing basis by running a set of calibration 
standards (standard curve) with each batch or run. In this case, it is important that linearity 
be evaluated and that the lower and upper standards are respectively below and above the 
expected range of the results as precision cannot be assessed on extrapolated results. Where 
possible, calibration standards should be traceable to absolute numbers or to recognized 
international units. 
Other factors that may need to be evaluated include the limit of detection defined as the 
lowest quantity of analyte that can be reliably detected above background noise levels and 
the limits of quantification that define the extremities at which the measurement response to 
changes in the analyte remains linear (Berwouts, 2010). 
 
Systematic error
Random error
Total error
Trueness
Precision
Repeatability,  intermediate precision,
reproducibility
Accuracy
Bias
Standard deviation
Measurement
uncertainty
Type of error
Performance 
characteristic Description (Metric)
 
Fig. 5. Performance characteristics, error types and measurement metrics uses for qualitative 
methods (adapted from Menditto et al., 2007). 
2.2.2 Qualitative methods 
This is an extreme form of a categorical test/method, in which there are only two result 
categories, positive and negative. This binary categorization can be based either on a cut-off 
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to a quantitative result. The diagnostic accuracy of a qualitative method can be characterized 
by two components, both of which can be calculated: sensitivity (the proportion of positive 
results correctly identified by the method), and specificity (the proportion of negative results 
correctly identified by the method). 
3. Parameters required for considering in the validation or revalidation of a 
method 
There are several measurable parameters that should be taken into account during 
validation or verification. The estimation of accuracy is a key parameter. Accuracy consists of 
both precision and trueness for quantitative and semiquantitative test/method. Precision or 
“closeness of agreement between results of replicate measurements” includes the following: 
Repeatability: within-run variation (same sample, same conditions). 
Intermediate precision: between-run variation within a single laboratory (different samples, 
operators, equipments). 
Reproducibility: between-run variation in different laboratories (different samples, operator). 
Robustness: variation when confronted with relevant challenges (e.g., sample type, 
environmental conditions and so on). 
Trueness is the “closeness of agreement with a reference value”. Appropriate reference 
materials are, therefore, essential and could include positive and negative/normal controls, 
certified reference materials, EQA materials, synthetic samples or material characterized by 
another technique.  
The components of accuracy for quality tests/methods are sensitivity and specificity. 
Sensitivity is a measure of how well the test/method detects positive results, whereas 
specificity describes how well negatives are detected. 
Thorough documentation during a validation process is essential, especially in the context 
of accreditation process pragmatic approaches, reconciling the formal requirements of 
accreditation standards while respecting the aim that “validation must be practical”, such as 
the design of IQC based on validation results, making full use of data that laboratories are 
already collecting, for example from IQC or EQA, for continuous validation. There are no 
detailed practical guides for validation of diagnostic methods in medical laboratories; 
moreover, the accreditation standards have no specific details about how to fulfil their 
requirements. The laboratory must decide on this, on the basis of their experience and 
performance requirements; it is duty of the laboratory to provide evidence that tests results 
provided are reliable, and that the performance claims are correct (Burnett, 2006; Hauck et 
al., 2008). 
In the end, validation is never finished. The implementation of quality indicators for 
systematically monitoring and evaluating the laboratory’s contribution to patient care is 
good way to continuously validate diagnostic tests/methods, apart from IQC, EQA and 
other data (Eurachem, 2010; Hauck et al., 2008). 
But when the method has already implemented several years and with performance and 
optimal quality specifications, we recommend periodic revalidation through the information 
provided by the treatment program reports or international interlaboratory comparison or 
testing fitness, programs or external quality control, in which the laboratory has been 
involved for years. The advantage of this validation methodology described above, is to 
estimate the imprecision, bias and uncertainty, without much effort and without having to 
make a lot of trials and experimental trials that would mean stopping the routine work in 
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the laboratory. You can validate the micro-range or specific concentration range, applicable 
as diagnostic daily reality for clinical laboratories.  
3.1 Estimation of the accuracy using reference materials 
ISO 15189 accreditation for clinical laboratories require a verification of the accuracy of the 
measurement procedures. The study of the accuracy, by estimating the systematic error, 
should be in the validation of the measurement. To study the accuracy of a measurement 
procedure is necessary to compare average values obtained with a conventional true value. 
In the clinical laboratory can be used as true values considered, mainly 3 types: value 
assigned to a reference material, the consensus value obtained in a program of external 
quality assessment, the value obtained with a reference measurement procedure. 
The accuracy is expressed numerically by systematic error, which is the difference between 
the average measurement results obtained and a conventional true value. The values 
assigned to some reference materials may be considered conventionally true values. 
The reference materials used in the study must have a value assigned to the magnitude that 
is measured and the corresponding value of uncertainty. You should also know the 
traceability of the assigned value. It is preferable that the material has a matrix similar to 
human samples. The main types of materials: certified reference materials, prepared by 
metrology institutes or other organizations related to metrology and reference materials 
business (controls to the truth). 
The reference material manufacturer must provide the traceability and uncertainty of 
assigned values; the latter expressed as standard uncertainty or expanded uncertainty. 
Along with the uncertainty value must also specify the coverage factor used. 
The results of accuracy studies should be used to validate the accuracy of the measurement 
procedures, ensures the absence of relevant and introduce systematic errors in the 
calculation of uncertainty of measurement uncertainty components associated with any 
correction factors. 
3.2 Estimation of the accuracy from participation in external quality assessment 
programs 
The external quality control includes different activities aimed at assessing the accuracy of 
the results through the intervention of an organization outside the laboratory. The most 
common form of external quality control is comparisons between laboratories or programs 
of external quality assessment. 
These programs are organized by professional associations, government agencies or 
manufacturers of control materials that have a similar function. Participating laboratories 
measured once a magnitude of a control material of unknown value. Organization of the 
program collects the results of laboratory and a study of the data then forwarded to each 
participating laboratory, informing about the error of its outcome. The duration of the 
program, the number of measurements that are performed and the number of different 
materials are used, depending on the different programs. To study the accuracy is 
recommended that the program in which you participate fulfill the following conditions: 
high number of participants, the laboratory has a minimum of 12 results for participation 
and that you know the standard deviation characterizes the dispersion of results among 
participating laboratories. 
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3.3 Estimation of measurement uncertainty 
The results provided by the clinical laboratory must be accurate (true and precise) to allow a 
correct clinical interpretation and to be comparable with earlier or later and between 
laboratories. 
The error of measurement of clinical laboratory results is almost always unknown. Instead, 
it is possible to ascribe a measurement uncertainty and metrological traceability of each 
result. The uncertainty is a numerical expression of the degree of doubt of the result. 
Traceability relates the result with reference values established allowing reproducibility 
over time and between laboratories (Eurachem, 2010). 
In the estimation of measurement uncertainty is assumed that any systematic error is 
eliminated, corrected or ignored, random effects are assessed on the outcome of an action 
and establishing a range within which lies the true value of the measured magnitude a 
certain level of confidence. The standard for laboratory accreditation ISO 15189 requires an 
estimate of the uncertainty of the results. The appropriate methodology for estimating the 
uncertainty described in the Guide to the Expression of Uncertainty in Measurement 
(GUM). The GUM was developed jointly by several international organizations for 
standardization and metrology for use in calibration and testing laboratories and measures 
applied to physical or chemical analysis. Currently, the GUM is difficult to apply to 
measures that are performed in clinical laboratories, although they maintained their 
principles. Moreover, the complexity and cost of obtaining an estimate of the uncertainty of 
measurement must be commensurate with the quality requirements applicable to the 
clinical use of the results. 
Sources are contributing to the uncertainty of a result as follows: sample collection, sample 
preparation, calibrators or reference materials, input quantities (e.g., absorbance), computer 
equipment used, environmental conditions, sample stability and changes in workers. 
The uncertainty associated with the collection and sample preparation is difficult to estimate 
and should be reduced through rigorous standardization of procedures. In this paper only 
consider the sources of uncertainty in the analytical phase, which begins when the sample 
interacts with the first technical step of the measurement (for example, placing the sample 
into an analyzer) and ends with obtaining a value numerical measurement result. 
The main components of the uncertainty of the analytical phase correspond to the 
uncertainty of the measured, the stability of the sample in the measurement system 
calibration, the volume dispensed, the batch of reagents, instrumentation equipment, 
operators and environmental conditions. In the following paragraphs, are discussed in more 
detail the main components. 
Measurement uncertainty is a parameter that is specifically associated with each outcome. In 
clinical laboratories, it is impossible to estimate particular measurement uncertainty for each 
measurand of each sample, so it makes a rough estimate of the uncertainty of measurement 
for a measurand defined and values of the same close to decision clinic. Measurement 
uncertainty does not apply to qualitative tests, in which the result is a numeric value. 
3.3.1 Definition of measurand 
The measurand is defined by the following parameters: 
a. Analyte to be measured. For example, protein, sodium ion, cholesterol, ASO, 
hemoglobin, white blood cell counts, etc. 
b. System. For example, serum, urine, venous blood, pleural fluid, etc. 
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c. Type size and unity. For example, substance concentration (mmol/L), mass 
concentration (g/L), catalyst concentration (nkat/L), etc. 
d. Measurement procedure.  
The existence of different molecular forms of the analyte can introduce uncertainty in the 
results. This source of uncertainty can be reduced or eliminated by careful definition of the 
measurement,  so they may react differently to some or other molecular forms. 
Another source of uncertainty regarding the definition of the measurand are possible cross-
reactions and interference that can occur with some samples and must be identified and 
documented to prevent, where possible, their influence. 
In short, uncertainty caused by the uncertainty of the measurand can not be quantified, but 
may be reduced or eliminated by detailed specification of the measurand. 
3.3.2 Imprecision 
Most of the components of measurement uncertainty of the analytical phase are contained in 
the estimation of imprecision (CVid). It is usually obtained using control materials. 
This assessment should be a sufficient number of data to collect the different sources of 
uncertainty apply, i.e.,  a minimum of six months of data and new estimation every year. In 
the period of data collection should include several calibrations to collect the uncertainty 
generated by the calibration process. Moreover it is necessary to use different batches of 
calibrator if you have the uncertainty of the assigned value. 
The estimate of CVid is made for a measurement value close to the values of clinical decision. 
3.3.3 Value assigned to the calibrator 
The clinical laboratory must know the uncertainty and metrological traceability of values 
assigned to calibration materials used. As usual it is commercial material the manufacturer 
must provide such data (Directive 98/79/EC). Along with the uncertainty value must also 
specify the coverage factor used. Typically, uncertainty is expressed as expanded 
uncertainty (U) for a confidence level of 95% (coverage factor = 2). 
The standard uncertainty (u) is calculated by dividing U by the coverage factor. 
U on (%) of the value assigned to the gauge should not vary excessively batch to batch and 
should generally be lower than CVid. 
3.3.4 Systematic error (bias) 
The estimation of measurement uncertainty is assumed that any significant systematic error 
of the measurement procedure has been deleted, corrected or ignored. The identification of a 
possible systematic error should be done during the validation of the measurement 
procedure. 
When systematic error is corrected by a factor, the correction has an associated uncertainty 
(ucf) that should be considered in calculating the combined measurement uncertainty. 
Systematic errors caused in the routine use of the measurement by the inevitable differences 
between different calibrations behave randomly in the long term, so this component of 
uncertainty is reflected in CVid. 
3.3.5 Uncertainty calculation 
The uncertainty is calculated by combining various sources. For this reason, clinical 
laboratories should identify each measurand, specifying the measurement procedure, and 
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calculate for each of them calculate the combined uncertainty from the data of internal 
quality control and other data, using the following equation: 
 2 2 2c id cal cfu CV u u     
Where: 
uc: relative combined standard uncertainty (%); CVid: imprecision (coefficient of variation) 
interday; Ucal: relative standard uncertainty (%) of the value assigned to the calibrator;  ucf: 
relative standard uncertainty (%) of the factor used to correct a systematic error. 
It is recommended to express the combined uncertainty for a confidence level of 95% 
(expanded uncertainty, Uc). To do this, multiply the value of uc for k = 2. 
 2 2 22c id cal fcU CV u u      
The relative expanded uncertainty should be expressed to two significant figures, for 
example: 4.2%, 16%. 
3.3.6 Interpretation 
The estimation of measurement uncertainty provides a quantitative indication of the level of 
doubt that the laboratory has in each result and is therefore a key element in the system of 
analytical quality in clinical laboratories. 
The relative expanded uncertainty of a measurand should be less than one third of the 
Maximum Permitted Error (MPE). If it was superior, should be studied in greater detail the 
different sources of uncertainty, identify the most significant and perform the appropriate 
actions to reduce them. 
3.3.7 Applications 
The uncertainty of measurement should be used primarily for: 
- Selection of measurement procedures that fulfill the specifications of accuracy. 
- Strict interpretation of the significance of a change between two consecutive values of 
magnitude biochemistry. 
- Strict interpretation of the significance of a result compared with a value of clinical 
decision. 
3.3.8 Limitations 
The value of the measurement uncertainty varies with the concentration of the measurand 
and may be substantially different for very low or very high analyte. For this reason it is 
recommended that the estimate for a concentration closes to clinical decision values. 
3.4 Estimation of precision 
Precision is one of the most important metrological characteristics to be considered for 
selection and implementation of a measurement procedure in the clinical laboratory. In 
addition, the quantitative understanding of this feature is essential for establishing tolerance 
intervals of internal control materials for the objective interpretation of the significance of a 
change between two consecutive values of magnitude biochemistry, and the calculation of 
uncertainty. 
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The accuracy can be studied under conditions of repeatability, reproducibility and 
intermediate. The study conditions that are more interested in the clinical laboratory are the 
kind of repeatability and intermediate terms, which vary from day to day. 
Before starting the study a period of familiarization with the measurement procedure and 
the operator's experience are recommended. 
Also for this study is recommended that samples for this study were commercial materials 
or control samples. We recommend using at least two samples with different concentrations 
of the magnitude under study, with a value within the physiological range or close to a 
discriminate value, and one with a pathological value. When it sees fit, they can not be 
tested with values close to the limits of the measuring range of the procedure. Samples 
should be stable during the duration of the study. If using commercial control materials, 
whenever possible, they should be interchangeable with samples of human origin. 
The run imprecision were obtained under the same conditions of repeatability, ie the same 
samples, the same operator, the same components of the measurement system for a short 
time and without calibrations between measurements. A minimum of 30 measurements are 
required for fulfilling statistical criteria. 
If the results of the run imprecision are not consistent with previous results, either supplied 
by the manufacturer or obtained in the literature, the study should be stopped to find and 
correct the cause of the discrepancy. 
Imprecision is obtained under certain conditions. Each laboratory should perform the 
estimation with standard calibration frequency (daily weekly, etc), and changes of operator, 
calibrator lot, reagent lot, etc, which are common in everyday work. Following the statistical 
criteria are recommended to estimate a minimum of 30 days. 
Before calculating the mean, standard deviation and coefficient of variation of the results 
must be detected the presence of possible outliers. An abnormal result will be removed 
provided that it is related to a documented error or has demonstrated statistically that is an 
outlier. After the removal of outliers, if any, imprecision is calculated by the coefficient of 
variation. 
4. Documentation: procedures and instructions needed for the validation of a 
method in the clinical laboratory 
International Standard ISO 15189:2007 clearly identifies the documentation requirements 
necessary to determine compliance with the requirements referred to for quality and 
competence of clinical laboratories. 
Standard clinical laboratory means (paragraph 3.8) that "laboratory devoted to biological, 
microbiological, immunological, chemical, immunohematological, biophysical, cytological, 
pathological or other material derived from the human body in order to provide diagnostic 
information, prevention and treatment of diseases or the assessment of human health and 
can provide a consultant advisory service covering all aspects of laboratory analysis, 
including interpretation of the findings and recommendations on any proper analysis 
additional". 
The implications of documentary that suggests the validation of a method, it follows that it 
must develop a set of documents or records.  
Registration means that documentary evidence of a fact that has occurred and is understood 
by documentary evidence to document that describes how the activities should be 
conducted.  
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According to these definitions it is able to state that the laboratory should have a defined 
overall validation procedure (document) that describes: What activities will be performed; 
responsibility to perform; records to retain; how to be performed. 
To confirm the verification of compliance, apply the method to real matrices, records to keep 
are: 1. Requirements applied to the method (Must be defined prior to conducting the tests, 
indicating preserved based on what have been defined); 2.Records of previous tests. 
(Straight calibration standards used, results obtained from different computers, etc.); 
3. Written procedure (approved by qualified personnel); 4. Results of tests for checking 
compliance with requirements (The laboratory must clearly indicate the results of the 
parameters and the comparison with the specified requirements); 5. Statement by the head 
of the validation of the procedure is suitable for their intended use based on the evidence 
(All these records should include dates, personnel and equipment used in ways that can be 
reconstructed). 
It must have an overall validation procedure describing the activities undertaken; those 
responsible for conducting, records to keep (the method established requirements, records 
of tests: calibration lines, patterns, etc.).  
 
ObservationsValueParameter
Design/planning of the method
validation
Objectives:
Procedure/codification:
References:
Used:
Responsible for validation:
Page X of Y
Review:
CODE:
Date:
“Name of the Laboratory”Registration
Method:
Lab logo
 
Fig. 6. Template record: Design / planning of the method validation. 
It must be developed and used a generic template so that it is not necessary to have to 
develop a validation process for each method, but simply change the data in the template. 
Thus, for any method in the laboratory which will continue to want to validate one of the 
two ways described: the classical or from the results of inter-comparison programs. It is 
used for the models listed in the Annexes to this case: report validation, design / planning 
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of the method validation, quality control plan method. They detail steps for each procedure 
to be followed in the validation. 
Here are a few examples of formats and / or templates of records that are considered 
necessary for the validation of a method: 
 Template record: Design / planning of the method validation (figure 6). 
 Template record: Report of validation (figure 7). 
 Registration: Plan quality control method (figure 8). 
 Title page of a validation procedure in clinical laboratory methods (figure 9). 
 Technical Registration. Spreadsheets (Excel) (figure 10). 
 
 
 
 
 
 
 
LAB LOGO
“Name of the laboratory”
Date:
Code:VALIDATION REPORT  
Review
Page X of Y
Date of procedure 
of validation
Register Observations Personnel
Additional data
Parameter Result /value Observations
Declaration:
Validated method
No validated method
Validated method with restrictions
Validation criteria:
Date of validation of the method: Signature: (Responsible of validation)
 
 
 
 
 
 
Fig. 7. Template record: Report of validation. 
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Lab logo Registration “Name of the Laboratory”
Date:
CODE:
Quality control plan method
Review:
Page X of Y
Method for validation
(Description)
Quality Control Periodicity Acceptance criteria
Accuracy
Trueness
Precision
Repeateability
Reproducibility
Uncertainty
Robutness
Specificity
LOQ
 
Fig. 8. Registration: Plan quality control method. 
LAB LOGO
MANUAL OF PROCEDURES “Name of the laboratory”
Date:
Code:PROCEDURE FOR VALIDATION METHODS
Review
Page X of Y
PROCEDURE FOR VALIDATION METHODS
Developed Revised Approved
Date
Technical Manager Quality Manager Lab Director
 
Fig. 9. Title page of a validation procedure in clinical laboratory methods 
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LAB LOGO
MANUAL OF PROCEDURES “Name of the laboratory”
Date:
Code:PROCEDURE FOR VALIDATION METHODS
Review
Page X of Y
CONTENTS
1. OBJECTIVE AND SCOPE
2. DEFINITIONS
3. REFERENCE DOCUMENTS
4. PROCEDURE
4.1. Accuracy
4.2.Precision
4.3.Trueness
4.4. Repeateability
4.5.Reproducibility
4.6. Uncertainty
4.7. Another validation parameters
5. ANNEXES
 
Fig. 10. Contents in a validation procedure in clinical laboratory. 
5. Conclusion  
It is important to have documented procedures for the validation of different diagnostic 
methods available within a clinical laboratory. There is a need to develop practical 
guidelines for method validation procedures in clinical laboratories through the various 
tools available to the laboratory. There is no single way to validate a diagnostic and clinical 
laboratory validate and verify the validation of their methods over time to meet the 
requirements of the existing accreditation standards and to demonstrate the laboratory's 
technical competence to offer quality results. 
6. References  
Berwouts, S.; Morris, M.A. & Dequeker, E. (2010).Approaches to quality management and 
accreditation in a genetic testing laboratory. European Journal of Human Genetics. 
No.18, pp. 1-19. 
Burnett, D. (2006). ISO 15189:2003-quality management, evaluation and continual 
improvement. Clin Chem Lab Med. No. 44, pp. 133-739. 
Burnett, D. & Blair, C. (2001). Standards for the medical laboratory-harmonization and 
subsidiarity. Clin Chem Acta. No. 309, pp. 137-145. 
Burnett, D.; Blair C.; Haeney, M.R.; Jeffcoate, S.L.; Scott, K.W. & Williams, D.L. (2002). 
Clinical pathology accreditation: standards for the medical laboratory. J Clin Pathol. 
No. 55, pp. 729-733. 
www.intechopen.com
 
Modern Approaches To Quality Control 
 
228 
Eurachem. (May 2010). The firness for purpose of analytical methods a laboratory guide to 
method validation and related topics, Avaliable from: 
 http://www.eurachem.org/guides/valid.pdf 
Hauck, W.W.; Kock, W.; Abernethy, D. &Williams, R.L. (2008). Making sense of trueness, 
precision, accuracy and uncertainty. Pharmacopeial Forum. No.34, pp.838-842. 
International Organization for Standardization. Medical laboratories-Particular   
requirements for quality and competence. ISO 15189:2007. 
International Organization for Standardization: General requirements for the competence of 
testing and calibration laboratories.ISO/IEC 17025:2005. 
Menditto, A.; Patriarca, M. & Magnusson, B. (2007). Understanding the meaning of 
accuracy, trueness and precision. Accred Qual Assur. No. 12, pp.45-47. 
www.intechopen.com
Modern Approaches To Quality Control
Edited by Dr. Ahmed Badr Eldin
ISBN 978-953-307-971-4
Hard cover, 538 pages
Publisher InTech
Published online 09, November, 2011
Published in print edition November, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Rapid advance have been made in the last decade in the quality control procedures and techniques, most of
the existing books try to cover specific techniques with all of their details. The aim of this book is to
demonstrate quality control processes in a variety of areas, ranging from pharmaceutical and medical fields to
construction engineering and data quality. A wide range of techniques and procedures have been covered.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
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